Analyst Ratings for Affimed Therapeutics (AFMD)

AFMD Rating Summary

AFMD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AFMD
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.80 (+40.7%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/31/2021 Credit Suisse
» Updated 4/7/2021
Brad Canino New Coverage Outperform
(N/A)
15.00
(N/A)
7.32
(9.81)
34.02% Details
3/28/2019 SVB Leerink N/A New Coverage Outperform
(N/A)
8.00
(N/A)
4.07
(9.81)
141.03% Details
Like AFMD Ratings? Also take a look at XOMA

AFMD Ratings News